Assyro AI

Orange Book product · Generic (ANDA)

HEPARIN SODIUM

HEPARIN SODIUM

Generic (ANDA)ANDA 208827DISCN B BRAUN MEDICAL

At a glance

Nov 19, 2018

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 19, 2018

    7 yr 8 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

HEPARIN SODIUM

Strength

5,000 UNITS/0.5ML

Dosage form

INJECTABLE

Route

INJECTION

TE code

Not listed

Application

ANDA 208827

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of HEPARIN SODIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.